no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia
|
Roman, L.D. |
|
2007 |
106 |
3 |
p. 558-566 9 p. |
article |
2 |
A phase II trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biomarkers of angiogenesis: A gynecologic oncology group study
|
McMeekin, D. Scott |
|
2007 |
106 |
3 |
p. 596-603 8 p. |
article |
3 |
Curcumin down-regulates Ets-1 and Bcl-2 expression in human endometrial carcinoma HEC-1-A cells
|
Yu, Ziming |
|
2007 |
106 |
3 |
p. 541-548 8 p. |
article |
4 |
Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma
|
Tebes, Stephen J. |
|
2007 |
106 |
3 |
p. 482-487 6 p. |
article |
5 |
Defining practice patterns in Gynecologic Oncology to prevent pulmonary embolism and deep venous thrombosis
|
Martino, M.A. |
|
2007 |
106 |
3 |
p. 439-445 7 p. |
article |
6 |
Duration of second or greater complete clinical remission in ovarian cancer: Exploring potential endpoints for clinical trials
|
Harrison, Michelle L. |
|
2007 |
106 |
3 |
p. 469-475 7 p. |
article |
7 |
Editorial Board
|
|
|
2007 |
106 |
3 |
p. iv- 1 p. |
article |
8 |
Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer
|
Walker, Graeme |
|
2007 |
106 |
3 |
p. 461-468 8 p. |
article |
9 |
Extreme drug resistance is common after prior exposure to paclitaxel
|
Geisler, John P. |
|
2007 |
106 |
3 |
p. 538-540 3 p. |
article |
10 |
Final results of a phase 2 study using continuous 5% Imiquimod cream application in the primary treatment of high-grade vulva intraepithelial neoplasia
|
Le, Tien |
|
2007 |
106 |
3 |
p. 579-584 6 p. |
article |
11 |
Genital human papilloma virus infection in mentally-institutionalized virgins
|
Shimada, Takako |
|
2007 |
106 |
3 |
p. 488-489 2 p. |
article |
12 |
Gynecologic Oncology Group risk groups for vulvar carcinoma: Improvement in survival in the modern era
|
Landrum, Lisa M. |
|
2007 |
106 |
3 |
p. 521-525 5 p. |
article |
13 |
Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III
|
Einstein, Mark H. |
|
2007 |
106 |
3 |
p. 453-460 8 p. |
article |
14 |
Impact of p53 immunostaining in predicting advanced or recurrent placental site trophoblastic tumors: A study of 12 cases
|
Nagai, Yuichiro |
|
2007 |
106 |
3 |
p. 446-452 7 p. |
article |
15 |
Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: A cost-effectiveness analysis
|
Bristow, Robert E. |
|
2007 |
106 |
3 |
p. 476-481 6 p. |
article |
16 |
Laparoscopic management of early uterine cancer: 10-Year experience in Asan Medical Center
|
Cho, Yun-Hyun |
|
2007 |
106 |
3 |
p. 585-590 6 p. |
article |
17 |
Laparoscopic sentinel lymph node mapping for cervix cancer—A detailed evaluation and time analysis
|
Kushner, David M. |
|
2007 |
106 |
3 |
p. 507-512 6 p. |
article |
18 |
Multivisceral cytoreductive surgery in FIGO stages IIIC and IV epithelial ovarian cancer: Results and 5-year follow-up
|
Scholz, Heinz S. |
|
2007 |
106 |
3 |
p. 591-595 5 p. |
article |
19 |
Overexpression of epidermal growth factor type-1 receptor (EGF-R1) in cervical cancer: Implications for Cetuximab-mediated therapy in recurrent/metastatic disease
|
Bellone, Stefania |
|
2007 |
106 |
3 |
p. 513-520 8 p. |
article |
20 |
Pathologic findings and outcomes for octogenarians presenting with uterine malignancy
|
Moore, Kathleen N. |
|
2007 |
106 |
3 |
p. 572-578 7 p. |
article |
21 |
Primary retroperitoneal mucinous borderline tumor: A case report
|
Cottrill, Hope M. |
|
2007 |
106 |
3 |
p. 626-627 2 p. |
article |
22 |
Primitive neuroectodermal tumor of the myometrium with cardio-vascular symptoms
|
Mir, Olivier |
|
2007 |
106 |
3 |
p. 622-625 4 p. |
article |
23 |
Re: “Feasibility of ovarian preservation in patients with early stage endometrial carcinoma”
|
Mahajan, Niraj N. |
|
2007 |
106 |
3 |
p. 631-632 2 p. |
article |
24 |
Re: Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer
|
Mahajan, Niraj N. |
|
2007 |
106 |
3 |
p. 631- 1 p. |
article |
25 |
Response to Letter to the Editor
|
Lee, Taek Sang |
|
2007 |
106 |
3 |
p. 632- 1 p. |
article |
26 |
Sentinel lymph node detection in early stage uterine cervix carcinoma: A systematic review
|
van de Lande, Jonas |
|
2007 |
106 |
3 |
p. 604-613 10 p. |
article |
27 |
Surgicopathologic outcome of laparoscopic versus open radical hysterectomy
|
Ghezzi, Fabio |
|
2007 |
106 |
3 |
p. 502-506 5 p. |
article |
28 |
The role of angiogenesis and COX-2 expression in the evolution of vulvar lichen sclerosus to squamous cell carcinoma of the vulva
|
Raspollini, Maria Rosaria |
|
2007 |
106 |
3 |
p. 567-571 5 p. |
article |
29 |
Treatment of squamous cell vulvar cancer with the anti-EGFR tyrosine kinase inhibitor Tarceva
|
Olawaiye, Alexander |
|
2007 |
106 |
3 |
p. 628-630 3 p. |
article |
30 |
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its therapeutic potential in breast and gynecologic cancers
|
Kendrick, James E. |
|
2007 |
106 |
3 |
p. 614-621 8 p. |
article |
31 |
Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment
|
Badgwell, Donna |
|
2007 |
106 |
3 |
p. 490-497 8 p. |
article |
32 |
VEGF- and LPA-induced telomerase in human ovarian cancer cells is Sp1-dependent
|
Bermudez, Yira |
|
2007 |
106 |
3 |
p. 526-537 12 p. |
article |
33 |
Venous thromboembolism prophylaxis: Is two better than one?
|
Einstein, M. Heather |
|
2007 |
106 |
3 |
p. 437-438 2 p. |
article |
34 |
Vesicovaginal fistula formation in patients with Stage IVA cervical carcinoma
|
Moore, Kathleen N. |
|
2007 |
106 |
3 |
p. 498-501 4 p. |
article |
35 |
Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions
|
Cricca, Monica |
|
2007 |
106 |
3 |
p. 549-557 9 p. |
article |